Cormorant Asset Management as of June 30, 2015
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 80 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes SHS (ALKS) | 6.0 | $45M | 700k | 64.34 | |
| Heron Therapeutics (HRTX) | 6.0 | $45M | 1.4M | 31.16 | |
| Receptos | 5.6 | $42M | 220k | 190.05 | |
| Alder Biopharmaceuticals | 5.3 | $40M | 758k | 52.97 | |
| Dyax | 4.9 | $37M | 1.4M | 26.50 | |
| Neurocrine Biosciences (NBIX) | 4.6 | $34M | 719k | 47.76 | |
| Sorrento Therapeutics Com New (SRNE) | 4.6 | $34M | 1.9M | 17.62 | |
| Eagle Pharmaceuticals (EGRX) | 3.2 | $24M | 300k | 80.86 | |
| Ardelyx (ARDX) | 3.1 | $24M | 1.5M | 15.97 | |
| Portola Pharmaceuticals | 3.0 | $23M | 500k | 45.55 | |
| Novavax | 2.4 | $18M | 1.6M | 11.14 | |
| Tesaro | 2.3 | $17M | 291k | 58.79 | |
| Alnylam Pharmaceuticals (ALNY) | 2.2 | $17M | 140k | 119.87 | |
| Quotient SHS | 2.2 | $17M | 1.1M | 14.79 | |
| Coherus Biosciences (CHRS) | 2.2 | $16M | 569k | 28.90 | |
| Advaxis Com New | 2.2 | $16M | 800k | 20.33 | |
| Agenus Com New | 1.8 | $14M | 1.6M | 8.63 | |
| China Biologic Products | 1.7 | $13M | 112k | 115.16 | |
| Dex (DXCM) | 1.6 | $12M | 153k | 79.98 | |
| Pfenex | 1.6 | $12M | 625k | 19.40 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.6 | $12M | 500k | 23.43 | |
| Nevro (NVRO) | 1.5 | $11M | 209k | 53.75 | |
| Ultragenyx Pharmaceutical (RARE) | 1.4 | $10M | 102k | 102.39 | |
| BioCryst Pharmaceuticals (BCRX) | 1.3 | $10M | 680k | 14.93 | |
| Recro Pharma | 1.3 | $10M | 780k | 12.92 | |
| Regulus Therapeutics | 1.3 | $9.8M | 897k | 10.96 | |
| Forward Pharma A/s Sponsored Adr | 1.3 | $9.7M | 255k | 38.05 | |
| Curis | 1.2 | $8.7M | 2.6M | 3.31 | |
| Keryx Biopharmaceuticals | 1.1 | $8.2M | 826k | 9.98 | |
| Karyopharm Therapeutics (KPTI) | 1.1 | $8.2M | 301k | 27.21 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.1 | $8.0M | 450k | 17.84 | |
| Ovascience | 1.0 | $7.3M | 252k | 28.93 | |
| Omeros Corporation (OMER) | 0.9 | $7.0M | 389k | 17.99 | |
| Minerva Neurosciences | 0.9 | $6.6M | 1.1M | 5.80 | |
| Epizyme | 0.8 | $6.4M | 266k | 24.00 | |
| Acceleron Pharma | 0.8 | $6.3M | 200k | 31.64 | |
| Array BioPharma | 0.8 | $6.1M | 850k | 7.21 | |
| Lipocine | 0.8 | $5.7M | 667k | 8.58 | |
| Aptose Biosciences Com New | 0.7 | $5.5M | 1.1M | 5.12 | |
| Rockwell Medical Technologies | 0.7 | $5.5M | 340k | 16.12 | |
| Epirus Biopharmaceuticals In | 0.7 | $5.1M | 897k | 5.71 | |
| Nektar Therapeutics (NKTR) | 0.7 | $5.0M | 398k | 12.51 | |
| Lion Biotechnologies | 0.6 | $4.6M | 500k | 9.17 | |
| Kite Pharma | 0.6 | $4.2M | 69k | 60.97 | |
| Sangamo Biosciences (SGMO) | 0.5 | $4.0M | 361k | 11.09 | |
| Immune Design | 0.5 | $3.9M | 189k | 20.65 | |
| Celyad Sa Adr | 0.5 | $3.9M | 75k | 52.03 | |
| Glycomimetics (GLYC) | 0.5 | $3.6M | 459k | 7.95 | |
| Acelrx Pharmaceuticals | 0.5 | $3.6M | 850k | 4.24 | |
| Dicerna Pharmaceuticals | 0.5 | $3.4M | 245k | 13.95 | |
| Dermira | 0.4 | $3.0M | 170k | 17.55 | |
| Tetralogic Pharmaceutical C Note 8.000% 6/1 | 0.4 | $3.0M | 5.0M | 0.60 | |
| Amicus Therapeutics (FOLD) | 0.4 | $2.8M | 200k | 14.15 | |
| AVEO Pharmaceuticals | 0.4 | $2.8M | 1.6M | 1.74 | |
| Blueprint Medicines (BPMC) | 0.4 | $2.6M | 100k | 26.49 | |
| Atara Biotherapeutics | 0.4 | $2.6M | 50k | 52.76 | |
| Versartis | 0.3 | $2.6M | 170k | 15.22 | |
| Cerulean Pharma | 0.3 | $2.5M | 551k | 4.60 | |
| Genvec Com New | 0.3 | $2.4M | 1.2M | 2.04 | |
| Htg Molecular Diagnostics | 0.3 | $2.2M | 201k | 11.15 | |
| Kindred Biosciences | 0.3 | $2.2M | 329k | 6.82 | |
| Seres Therapeutics (MCRB) | 0.3 | $2.1M | 50k | 41.50 | |
| Aquinox Pharmaceuticals | 0.3 | $1.9M | 280k | 6.94 | |
| Agile Therapeutics | 0.2 | $1.6M | 182k | 8.59 | |
| Veracyte (VCYT) | 0.2 | $1.5M | 138k | 11.14 | |
| Cellectar Biosciences Com New | 0.2 | $1.5M | 530k | 2.88 | |
| Nanostring Technologies (NSTGQ) | 0.2 | $1.2M | 80k | 15.43 | |
| Contrafect | 0.2 | $1.2M | 234k | 5.25 | |
| Provectus Biopharmaceuticals I (PVCT) | 0.2 | $1.2M | 2.2M | 0.54 | |
| Ascendis Pharma A S Spnsored Adr (ASND) | 0.1 | $1.1M | 62k | 17.67 | |
| Akebia Therapeutics (AKBA) | 0.1 | $1.0M | 100k | 10.29 | |
| Biotie Therapies Oyj Sponsored Adr | 0.1 | $999k | 50k | 19.98 | |
| Scynexis | 0.1 | $873k | 99k | 8.79 | |
| Galectin Therapeutics Com New (GALT) | 0.1 | $781k | 286k | 2.73 | |
| Provectus Biopharmaceuticals *w Exp 06/24/202 | 0.1 | $480k | 2.2M | 0.22 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $458k | 25k | 18.32 | |
| Cellectar Biosciences *w Exp 08/19/201 | 0.1 | $413k | 530k | 0.78 | |
| Cellectis S A Sponsored Ads (CLLS) | 0.1 | $408k | 11k | 36.11 | |
| Applied Genetic Technol Corp Com New | 0.0 | $262k | 17k | 15.31 | |
| Celsus Therapeutics Sponsored Adr Ne | 0.0 | $166k | 287k | 0.58 |
